Ondine Biomedical Inc.
OBIMF
$0.11
-$0.02-15.39%
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 889.90K | 899.50K | 2.26M | 2.20M | 3.35M |
Total Receivables | 173.90K | 175.80K | 246.90K | 241.00K | 73.30K |
Inventory | 941.10K | 951.20K | 807.20K | 788.00K | 821.60K |
Prepaid Expenses | 238.20K | 240.70K | 166.60K | 162.60K | 330.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 111.10K | 112.30K | 118.90K | 116.10K | 111.00K |
Total Current Assets | 2.35M | 2.38M | 3.60M | 3.51M | 4.69M |
|
|||||
Total Current Assets | 2.35M | 2.38M | 3.60M | 3.51M | 4.69M |
Net Property, Plant & Equipment | 560.40K | 566.40K | 718.60K | 701.50K | 878.30K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 26.30K | 26.60K | 26.50K | 25.90K | 26.40K |
Total Assets | 2.94M | 2.97M | 4.34M | 4.24M | 5.59M |
|
|||||
Total Accounts Payable | 1.38M | 1.39M | 1.03M | 1.01M | 176.00K |
Total Accrued Expenses | 1.14M | 1.15M | 1.32M | 1.29M | 1.52M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 256.50K | 259.20K | 289.30K | 282.40K | 302.80K |
Total Finance Division Other Current Liabilities | 157.10K | 158.80K | -- | -- | -- |
Total Other Current Liabilities | 157.10K | 158.80K | -- | -- | -- |
Total Current Liabilities | 2.93M | 2.96M | 2.64M | 2.58M | 2.00M |
|
|||||
Total Current Liabilities | 2.93M | 2.96M | 2.64M | 2.58M | 2.00M |
Long-Term Debt | -- | -- | -- | -- | 212.20K |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | 120.40K | 117.50K | 248.50K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.93M | 2.96M | 2.76M | 2.70M | 2.46M |
|
|||||
Common Stock & APIC | 186.58M | 188.58M | 189.44M | 184.94M | 185.73M |
Retained Earnings | -200.27M | -202.42M | -201.67M | -196.88M | -196.21M |
Treasury Stock & Other | 13.71M | 13.85M | 13.81M | 13.49M | 13.61M |
Total Common Equity | 13.90K | 14.00K | 1.58M | 1.54M | 3.13M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 13.90K | 14.00K | 1.58M | 1.54M | 3.13M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 13.90K | 14.00K | 1.58M | 1.54M | 3.13M |
|